-
1 Comment
22nd Century Group, Inc is currently in a long term uptrend where the price is trading 29.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
22nd Century Group, Inc's total revenue rose by 0.6% to $7M since the same quarter in the previous year.
Its net income has dropped by 3.3% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 3.4% to $-3M since the same quarter in the previous year.
Based on the above factors, 22nd Century Group, Inc gets an overall score of 3/5.
ISIN | US90137F1030 |
---|---|
Sector | Consumer Defensive |
Industry | Tobacco |
Exchange | NASDAQ |
CurrencyCode | USD |
PE Ratio | None |
---|---|
Beta | 1.96 |
Market Cap | 4M |
Target Price | 720 |
Dividend Yield | None |
22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for XXII using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025